SLCO1B1 and myopathy: A 2013 study of UK primary care recruited 77 patients with statin‐induced myopathy and found SLCO1B1*5 significantly increased risk of myopathy compared to controls (OR per *5 allele 2.1, 95% CI 1.3‐3.2),16 but more research is needed linking genotype and general practice (GP) data.